1
|
Smirnova DV, Rehm CD, Fritz RD, Kutepova IS, Soshina MS, Berezhnaya YA. Vitamin D status of the Russian adult population from 2013 to 2018. Sci Rep 2022; 12:16604. [PMID: 36198864 PMCID: PMC9533264 DOI: 10.1038/s41598-022-21221-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Accepted: 09/23/2022] [Indexed: 11/08/2022] Open
Abstract
Vitamin D deficiency is widespread globally, however available data for the Russian adult population is fragmented. This cross-sectional study used secondary data for individuals undergoing testing for vitamin D concentrations from 2013 to 2018 by InVitro laboratory. 25(OH)D serum concentration was determined using chemiluminescent microparticle immunoassay. The mean, median, and proportion with severe, deficient, insufficient and sufficient 25-hydroxyvitamin D (25(OH)D) concentrations were estimated. Splines examined the effect of latitude on 25(OH)D concentrations. Data were available for 30,040 subjects age ≥ 18 years. 24.2% of the sampled population had sufficient (30-< 150 25(OH)D ng/mL), 34% deficient (10-19.9 ng/mL) and 5.6% severely deficient (< 10 ng/mL) status. Average 25(OH)D concentrations were highest among 30-44 years and lowest amongst older adults; females had modestly higher values. Concentrations were 15% higher in fall/summer vs. winter/spring. A non-linear relationship was observed by latitude; the highest 25(OH)D concentrations were observed near 54°N, decreasing at more southern latitudes for women and more northern latitudes for both sexes. These results are comparable to other Northern European publications and limited Russian samples demonstrating low concentrations. Acknowledging that nationally-representative and randomly sampled data are needed, the present data suggest the burden may be high and identifies some population sub-groups and geographic areas with a higher potential deficiency of vitamin D.
Collapse
Affiliation(s)
- Daria V Smirnova
- PepsiCo R&D, Leningradsky prospect 72 k4, 125319, Moscow, Russia
| | | | | | - Inga S Kutepova
- PepsiCo R&D, Leningradsky prospect 72 k4, 125319, Moscow, Russia
| | - Maria S Soshina
- PepsiCo R&D, Leningradsky prospect 72 k4, 125319, Moscow, Russia
| | | |
Collapse
|
2
|
Moisejenko-Goluboviča J, Groma V, Svirskis Š, Ivanova A. Serum Vitamin D Levels Explored in the Latvian Cohort of Patients with Basal Cell Carcinoma Linked to the Sonic Hedgehog and Vitamin D Binding Protein Cutaneous Tissue Indices. Nutrients 2022; 14:nu14163359. [PMID: 36014865 PMCID: PMC9413259 DOI: 10.3390/nu14163359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 08/07/2022] [Accepted: 08/08/2022] [Indexed: 11/16/2022] Open
Abstract
Ultraviolet radiation is known as one of the major contributors to skin malignancies, including basal cell carcinoma (BCC), which is the most common type of skin cancer. It is a heterogeneous tumor, which presents with various types that are stratified into low- and high-risk tumors. Sunlight is important for overall health and vitamin D synthesis in the skin, whereas deviations from the optimal level of vitamin D are shown to be associated with the risk of the development of BCC. The accumulating evidence suggests the ability of vitamin D to antagonize the Sonic Hedgehog (SHH) signaling, the key tumor pathway, and play a protective role in the development of BCC. Additionally, a vitamin D binding protein (DBP) is shown to be implicated in the complex regulation of vitamin D. Here, we aimed to explore serum vitamin D in patients with different primary and recurrent BCC of the head and neck and investigate cutaneous DBP and SHH indices, confirmed immunohistochemically in these subjects. According to the results, 94.9% of the Latvian cohort of BCC patients were found to be deficient in vitamin D. No significant differences in serum vitamin D levels were found between genders, primary and recurrent tumors, and different types of BCC. Serum vitamin D was inversely associated with tumor size. Susceptible male individuals with low blood vitamin D levels were recognized at risk of developing aggressive and recurrent BCC confirmed by the use of hierarchical clustering analysis. In smaller tumors with a favorable course, such as superficial and nodular BCC, the association between high DBP and low SHH tissue expression was found, providing supportive evidence of the existence of a link between vitamin D, proteins involved in its metabolism, as exemplified by the DBP and SHH signaling pathway. The assumption of a deficiency in the protective effect of vitamin D in patients with high-risk BCCs was proposed in low DBP and high SHH tissue indices. New extensions to existing knowledge and characterization of the BCC signaling pathways and their cross-talk with vitamin D are warranted when searching for a preferential effect of vitamin D on skin cancer.
Collapse
Affiliation(s)
- Jeļena Moisejenko-Goluboviča
- Department of Doctoral Studies, Riga Stradins University, Dzirciema Street 16, LV-1007 Riga, Latvia
- Correspondence: ; Tel.: +371-26048005
| | - Valērija Groma
- Institute of Anatomy and Anthropology, Riga Stradins University, 9 Kronvalda Blvd., LV-1010 Riga, Latvia
| | - Šimons Svirskis
- Institute of Microbiology and Virology, Riga Stradins University, Rātsupītes Str. 5, LV-1067 Riga, Latvia
| | - Anna Ivanova
- Department of Maxillofacial Surgery, Institute of Stomatology, Riga Stradins University, Dzirciema Street 20, LV-1007 Riga, Latvia
| |
Collapse
|
3
|
Helde Frankling M, Klasson C, Björkhem-Bergman L. 25-Hydroxyvitamin D in Cancer Patients Admitted to Palliative Care: A Post-Hoc Analysis of the Swedish Trial 'Palliative-D'. Nutrients 2022; 14:nu14030602. [PMID: 35276963 PMCID: PMC8840761 DOI: 10.3390/nu14030602] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2021] [Revised: 01/21/2022] [Accepted: 01/27/2022] [Indexed: 12/15/2022] Open
Abstract
The purpose of this study is to explore 25-hydroxyvitamin D (25-OHD) levels in patients with cancer in the palliative phase in relation to season, sex, age, tumor type, colectomy, and survival. To this end, we performed a post-hoc analysis of ‘Palliative-D’, a randomized placebo-controlled, double-blind trial investigating the effect of daily supplementation with 4000 IU of vitamin D for 12 weeks on pain in patients in palliative cancer care. In the screening cohort (n = 530), 10% of patients had 25-OHD levels < 25 nmol/L, 50% < 50, and 84% < 75 nmol/L. Baseline 25-OHD did not differ between seasons or tumor type and was not correlated with survival time. In vitamin D deficient patients supplemented with vitamin D (n = 67), 86% reached sufficient levels, i.e., >50 nmol/L, after 12 weeks. An increase in 25-OHD was larger in supplemented women than in men (53 vs. 37 nmol/L, p = 0.02) and was not affected by season. In the placebo-group (n = 83), decreased levels of 25-OHD levels were noted during the study period for patients recruited during the last quarter of the year. In conclusion, cancer patients in palliative phase have adequate increase in 25-OHD after vitamin D supplementation regardless of season, age, tumor type, or colectomy.
Collapse
Affiliation(s)
- Maria Helde Frankling
- Karolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Blickagången 16, Neo Floor 7, SE-141 83 Huddinge, Sweden; (C.K.); (L.B.-B.)
- Thoracic Oncology Center, Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
- Correspondence:
| | - Caritha Klasson
- Karolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Blickagången 16, Neo Floor 7, SE-141 83 Huddinge, Sweden; (C.K.); (L.B.-B.)
- Stockholms Sjukhem, Palliative Medicine, Mariebergsgatan 22, SE-112 19 Stockholm, Sweden
| | - Linda Björkhem-Bergman
- Karolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Blickagången 16, Neo Floor 7, SE-141 83 Huddinge, Sweden; (C.K.); (L.B.-B.)
- Stockholms Sjukhem, Palliative Medicine, Mariebergsgatan 22, SE-112 19 Stockholm, Sweden
| |
Collapse
|
4
|
Lips P, de Jongh RT, van Schoor NM. Trends in Vitamin D Status Around the World. JBMR Plus 2021; 5:e10585. [PMID: 34950837 PMCID: PMC8674774 DOI: 10.1002/jbm4.10585] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 11/18/2021] [Accepted: 11/18/2021] [Indexed: 01/01/2023] Open
Abstract
Vitamin D status varies across all continents and countries. Vitamin D status usually is adequate in Latin America and Australia, but in contrast it is very low in the Middle East and some countries in Asia. Trends in vitamin D status, whether it improves or declines over the years, carry important messages. Trends usually are small, but can be predictors and indicators of general health. Vitamin D status has improved in the older population in the United States, and improvement relates to dairy use and vitamin D supplements. To the contrary, vitamin D status has declined in the Inuit population of Canada due to a change from a traditional fish diet to a Western diet. A large improvement was seen in Finland after mandatory fortification of dairy products was introduced. Determinants of decline are less sun exposure, increased use of sunscreen, increase of body mass index (BMI), less physical activity, and poor socioeconomic status. Determinants of increase are food fortification with vitamin D and vitamin D supplements. Food fortification can lead to a population-wide increase in vitamin D status as shown by the Finnish example. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Collapse
Affiliation(s)
- Paul Lips
- Department of Internal Medicine, Endocrine SectionAmsterdam University Medical Centre, location VUMCAmsterdamThe Netherlands
| | - Renate T. de Jongh
- Department of Internal Medicine, Endocrine SectionAmsterdam University Medical Centre, location VUMCAmsterdamThe Netherlands
| | - Natasja M. van Schoor
- Department of Epidemiology and Data ScienceAmsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam Public Health Research InstituteAmsterdamThe Netherlands
| |
Collapse
|
5
|
Ikonen H, Lumme J, Seppälä J, Pesonen P, Piltonen T, Järvelin MR, Herzig KH, Miettunen J, Niinimäki M, Palaniswamy S, Sebert S, Ojaniemi M. The determinants and longitudinal changes in vitamin D status in middle-age: a Northern Finland Birth Cohort 1966 study. Eur J Nutr 2021; 60:4541-4553. [PMID: 34137914 PMCID: PMC8572212 DOI: 10.1007/s00394-021-02606-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Accepted: 06/02/2021] [Indexed: 12/24/2022]
Abstract
PURPOSE Populations living in the Nordic countries are at high risk for vitamin D (VitD) deficiency or insufficiency. To reduce the risk, nationwide interventions based on food fortification and supplementation are being implemented. However, there is limited evidence about the impact of such public health campaigns on target populations. METHODS We studied an unselected sample of 3650 participants (56.2% females) from the longitudinal Northern Finland Birth Cohort 1966 with repeated measures of serum 25-hydroxyvitamin D [25(OH)D] at ages 31 (1997) and 46 (2012-2013). Timepoints corresponded to the period before and during the food fortification. We examined the effect of VitD intake from the diet and supplementation, body mass index and previous 25(OH)D concentration on 25(OH)D concentration at 46 years using a multivariable linear regression analysis. A 25(OH)D z score adjusted for sex, season, latitude and technical effect was used in the analysis. RESULTS We observed an increase of 10.6 nmol/L in 25(OH)D, when the baseline 25(OH)D was 54.3 nmol/L. The prevalence of serum 25(OH)D below < 50 nmol/L was halved. The changes were found for both sexes and were more pronounced in winter compared to summer months. Regular VitD supplementation had a significant positive effect on 25(OH)D at the age of 46, as well as had the dietary intake of fortified dairy products and fish, and the previous 25(OH)D concentration. However, the intake of fat-spreads albeit VitD-fortified, did not predict 25(OH)D. CONCLUSION Our results demonstrated the positive impact of the fortification programme on VitD status in middle-aged population.
Collapse
Affiliation(s)
- Helmi Ikonen
- Center for Life-Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland
| | - Johanna Lumme
- PEDEGO Research Unit, University of Oulu, 90014, Oulu, Finland.,Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014, Oulu, Finland.,Department of Obstetrics and Gynecology, Oulu University Hospital, 90220, Oulu, Finland
| | - Jussi Seppälä
- Center for Life-Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland.,Department of Mental and Substance Use Disorders, South Carelia Social and Healthcare District, 53130, Lappeenranta, Finland.,Social Insurance Institute of Finland, 70 110, Kuopio, Finland
| | - Paula Pesonen
- Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland
| | - Terhi Piltonen
- PEDEGO Research Unit, University of Oulu, 90014, Oulu, Finland.,Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014, Oulu, Finland.,Department of Obstetrics and Gynecology, Oulu University Hospital, 90220, Oulu, Finland
| | - Marjo-Riitta Järvelin
- Center for Life-Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland. .,Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, St. Mary's Campus, Imperial College London, London, W2 1PG, UK. .,Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Kingston Lane, Uxbridge, UB8 3PH, Middlesex, UK. .,Unit of Primary Care, Oulu University Hospital, 90220, Oulu, Finland.
| | - Karl-Heinz Herzig
- Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014, Oulu, Finland.,Institute of Biomedicine, Medical Research Center, University of Oulu, 90014, Oulu, Finland.,Institute of Pediatrics, Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, 60-572, Poznań, Poland
| | - Jouko Miettunen
- Center for Life-Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland.,Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014, Oulu, Finland
| | - Maarit Niinimäki
- PEDEGO Research Unit, University of Oulu, 90014, Oulu, Finland.,Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014, Oulu, Finland.,Department of Obstetrics and Gynecology, Oulu University Hospital, 90220, Oulu, Finland
| | - Saranya Palaniswamy
- Center for Life-Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland.,Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, St. Mary's Campus, Imperial College London, London, W2 1PG, UK
| | - Sylvain Sebert
- Center for Life-Course Health Research, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland.
| | - Marja Ojaniemi
- PEDEGO Research Unit, University of Oulu, 90014, Oulu, Finland.,Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014, Oulu, Finland.,Department of Pediatrics and Adolescence, Oulu University Hospital, 90220, Oulu, Finland
| |
Collapse
|